Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie P L Saw

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|May 29, 2026
Redefining first-line standards with new partnersStephanie P L Saw, Jordi Remon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 9, 2025
Distant Cousins From the Same Family-Understanding Uncommon EGFR MutationsStephanie P L Saw, Molly S C Li
The Lancet. Respiratory Medicine|August 19, 2024
Anti-CTLA-4 in non-small-cell lung cancer: insights from the NIPPON studyMolly S C Li, Stephanie P L Saw, Alfredo Addeo
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 1, 2024
New Treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung Cancer Focusing on <i>EGFR</i>-Mutant TumorsStephanie P L Saw, Xiuning Le, Lizza E L Hendriks, et al.
The Lancet. Oncology|February 5, 2026
Radiotherapy has a role to play in patients with EGFR-mutated non-small-cell lung cancer in first-line treatmentDirk De Ruysscher, Pim J J Damen, Lizza E L Hendriks, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2026
Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026Martina Bortolot, Stephanie P L Saw, Erica Pietroluongo, et al.
Cancer Treatment Reviews|May 11, 2026
KRAS G12C-mutant non-small cell lung cancer: A practical guide for cliniciansJordi Remon, Giulia La-Cava, Maxime Borgeaud, et al.
Expert Review of Anticancer Therapy|November 25, 2022
Immunotherapy with chemotherapy and anti-angiogenic therapy for <i>EGFR</i> mutated NSCLC: challenging the dogmaAaron C Tan, Keigo Kobayashi, Stephanie P L Saw, et al.
The Lancet. Oncology|November 4, 2021
Revisiting neoadjuvant therapy in non-small-cell lung cancerStephanie P L Saw, Boon-Hean Ong, Kevin L M Chua, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2023
Perioperative Treatment Strategies in EGFR-Mutant Early-Stage NSCLC: Current Evidence and Future ChallengesJordi Remon, Stephanie P L Saw, Francesco Cortiula, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|May 29, 2026
Redefining first-line standards with new partnersStephanie P L Saw, Jordi Remon
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 9, 2025
Distant Cousins From the Same Family-Understanding Uncommon EGFR MutationsStephanie P L Saw, Molly S C Li
The Lancet. Respiratory Medicine|August 19, 2024
Anti-CTLA-4 in non-small-cell lung cancer: insights from the NIPPON studyMolly S C Li, Stephanie P L Saw, Alfredo Addeo
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 1, 2024
New Treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung Cancer Focusing on <i>EGFR</i>-Mutant TumorsStephanie P L Saw, Xiuning Le, Lizza E L Hendriks, et al.
The Lancet. Oncology|February 5, 2026
Radiotherapy has a role to play in patients with EGFR-mutated non-small-cell lung cancer in first-line treatmentDirk De Ruysscher, Pim J J Damen, Lizza E L Hendriks, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2026
Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026Martina Bortolot, Stephanie P L Saw, Erica Pietroluongo, et al.
Cancer Treatment Reviews|May 11, 2026
KRAS G12C-mutant non-small cell lung cancer: A practical guide for cliniciansJordi Remon, Giulia La-Cava, Maxime Borgeaud, et al.
Expert Review of Anticancer Therapy|November 25, 2022
Immunotherapy with chemotherapy and anti-angiogenic therapy for <i>EGFR</i> mutated NSCLC: challenging the dogmaAaron C Tan, Keigo Kobayashi, Stephanie P L Saw, et al.
The Lancet. Oncology|November 4, 2021
Revisiting neoadjuvant therapy in non-small-cell lung cancerStephanie P L Saw, Boon-Hean Ong, Kevin L M Chua, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2023
Perioperative Treatment Strategies in EGFR-Mutant Early-Stage NSCLC: Current Evidence and Future ChallengesJordi Remon, Stephanie P L Saw, Francesco Cortiula, et al.
Pageof 3